Table 5.
Incidence of hypertension in the different uric acid groups during follow-up in 2011 and 2015.
| Case/Participants | Hypertension (%) | |
|---|---|---|
| Uric acid quartiles† In 2011 |
||
| Q1 | 1349/4806 | 166 (12.3) |
| Q2 | 1260/4806 | 167 (13.3) |
| Q3 | 1190/4806 | 182 (15.3) |
| Q4 | 1007/4806 | 191 (19.0) |
| P | <0.01 | |
| In 2015 | ||
| Q1 | 1106/3921 | 253 (22.9) |
| Q2 | 1027/3921 | 260 (25.3) |
| Q3 | 947/3921 | 249 (26.3) |
| Q4 | 841/3921 | 256 (30.4) |
| P | <0.01 |
†
Males: Q1 (SUA ≤ 4.86 mg/dL), Q2 (4.86 < SUA ≤ 5.73 mg/dL), Q3 (5.73 < SUA ≤ 6.79 mg/dL), and Q4 (SUA > 6.79 mg/dl).
Females: Q1 (SUA ≤ 3.55 mg/dL), Q2 (3.55 < SUA ≤ 4.29 mg/dL), Q3 (4.29 < SUA ≤ 5.23 mg/dL), and Q4 (SUA > 5.23 mg/dL).